Loading clinical trials...
Loading clinical trials...
Study of High-dose Chemotherapy Combined With Adoptive Cellular Therapy With Dentritic and Cytokine-induced Killer Cells in Triple Negative Breast Cancer Patients
Conditions
Locations
1
China
Beijing Cancer Hospital
Beijing, China
Start Date
August 1, 2010
Primary Completion Date
May 1, 2011
Completion Date
October 1, 2013
Last Updated
July 23, 2015
NCT07213804
NCT07191730
NCT06797635
NCT06312176
NCT07003841
NCT07046923
Lead Sponsor
Peking University Cancer Hospital & Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions